Celgene Corp. /de/ is 10% Owner at CRISPR Therapeutics AG (CRSP). They have made 30 open-market trades across 5 companies since 2013, most recently 2020-07-09.
14 open-market purchases totalling $277.9M since 2013, against 16 sales. Across 14 scored buys the stock is up 4.0% at ninety days, and 0.6 points ahead of the S&P over the same stretch.
14 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 29% | 57% | 57% |
| Avg Move | -10.1% | +0.7% | +4.0% |
| Alpha | -8.1% | -0.6% | +0.6% |
| Scored | 14 | 14 | 14 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 94% | 6% | 0% |
| Avg Move | -0.3% | +32.3% | +157.2% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XLRN | SELL | 2020-07-09 | 2020-07-13 | $102.28 | $458K | +14.2% | -4.5% | +23.4% |
| XLRN | BUY | 2020-07-01 | 2020-07-06 | $92.50 | $10.0M | -4.9% | +3.6% | +7.0% |
| XLRN | BUY | 2019-01-18 | 2019-01-22 | $43.00 | $30.4M | +3.9% | +2.0% | -2.6% |
| CRSP | SELL | 2017-12-04 | 2017-12-07 | $19.47 | $594K | -1.3% | +34.7% | +166.1% |
| CRSP | SELL | 2017-12-01 | 2017-12-07 | $19.10 | $1.7M | -1.3% | +34.7% | +166.1% |
| CRSP | SELL | 2017-11-30 | 2017-12-07 | $19.04 | $241K | -1.3% | +34.7% | +166.1% |
| CRSP | SELL | 2017-11-29 | 2017-12-07 | $19.25 | $82K | -1.3% | +34.7% | +166.1% |
| CRSP | SELL | 2017-11-28 | 2017-12-07 | $19.22 | $98K | -1.3% | +34.7% | +166.1% |
| CRSP | SELL | 2017-11-27 | 2017-12-07 | $19.75 | $553K | -1.3% | +34.7% | +166.1% |
| CRSP | SELL | 2017-11-20 | 2017-12-07 | $19.02 | $3.0M | -1.3% | +34.7% | +166.1% |
| CRSP | SELL | 2017-11-17 | 2017-12-07 | $18.44 | $946K | -1.3% | +34.7% | +166.1% |
| CRSP | SELL | 2017-11-14 | 2017-12-07 | $17.19 | $256K | -1.3% | +34.7% | +166.1% |
| CRSP | SELL | 2017-11-13 | 2017-12-07 | $17.76 | $1.2M | -1.3% | +34.7% | +166.1% |
| CRSP | SELL | 2017-11-09 | 2017-12-07 | $17.08 | $342K | -1.3% | +34.7% | +166.1% |
| CRSP | SELL | 2017-11-08 | 2017-12-07 | $18.06 | $305K | -1.3% | +34.7% | +166.1% |
| CRSP | SELL | 2017-11-06 | 2017-12-07 | $18.89 | $1.5M | -1.3% | +34.7% | +166.1% |
| CRSP | SELL | 2017-11-03 | 2017-12-07 | $17.60 | $19.6M | -1.3% | +34.7% | +166.1% |
| CRSP | SELL | 2017-11-03 | 2017-12-07 | $19.10 | $435K | -1.3% | +34.7% | +166.1% |
| XLRN | BUY | 2017-09-25 | 2017-09-25 | $37.00 | $27.6M | +8.9% | +4.4% | +21.2% |
| AGIO | BUY | 2017-04-24 | 2017-04-24 | $49.50 | $61.8M | -1.8% | -1.9% | +23.3% |
| ALQA | BUY | 2017-02-27 | 2017-03-01 | $0.50 | $2.0M | -8.2% | -18.6% | -40.2% |
| JNCE | BUY | 2017-02-01 | 2017-02-01 | $16.00 | $10.0M | +23.7% | +34.1% | +58.9% |
| CRSP | BUY | 2016-10-24 | 2016-10-27 | $14.00 | $11.2M | -3.1% | +25.4% | +14.9% |
| XLRN | BUY | 2016-01-11 | 2016-01-11 | $40.00 | $32.0M | +5.1% | -25.7% | -11.8% |
| ALQA | BUY | 2015-05-04 | 2015-05-04 | $4.55 | $3.0M | -21.9% | +2.3% | +2.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Scored | 16 | 16 | 16 |